Apoptosis of Hepatitis B Virus-expressing Liver Tumor Cells Induced by a High Concentration of Nucleos(t)ide Analogue

被引:3
作者
Tak, Eunyoung [1 ]
Hwang, Shin [2 ]
Lee, Han Chu [3 ]
Ko, Gi-Young [4 ]
Ahn, Chul-Soo [2 ]
Yoon, Young-In [2 ]
Lim, Young-Suk [3 ]
Jun, Dae-Young [1 ]
Kim, Ki-Hun [2 ]
Song, Gi-Won [2 ]
Moon, Deog-Bok [2 ]
Ryoo, Baek-Yeol [5 ]
Kim, Nayoung [1 ]
Lee, Sung-Gyu [2 ]
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, 88 Olymp Ro 43 Gil, Seoul 138736, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Diagnost Radiol, Seoul, South Korea
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
Tenofovir; entecavir; covalently closed circular DNA; HBV X protein; transcatheter arterial chemoembolization; TENOFOVIR DISOPROXIL FUMARATE; CLOSED CIRCULAR DNA; HEPATOCELLULAR-CARCINOMA; IMMUNOGLOBULIN MONOTHERAPY; HBSAG SEROCLEARANCE; CLINICAL-OUTCOMES; RECURRENCE; THERAPY; RISK; TRANSPLANTATION;
D O I
10.21873/anticanres.11195
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background/Aim: We investigated the expression of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) and HBV X protein (HBx) in human hepatocellular carcinoma (HCC) and evaluated the effect of high-concentration nucleos(t)ide analogs (NUCs) on liver tumor cell lines. Materials and Methods: This study consisted of three parts: part I used human blood and non-tumor liver tissues; part II used human HCC and adjacent liver tissues; and part III used an HBV-expressing liver tumor cell line. Results: There were close correlations among blood and liver HBV DNA and liver cccDNA. HBV cccDNA and HBx were highly up-regulated in HCC compared to adjacent liver tissues despite NUC therapy. HBV cccDNA and HBx were highly up-regulated in the cccDNA-expressing HepG2.2.15 cell line. Their expression was down-regulated and apoptosis was induced by a very high concentration of NUCs in dose-and time-dependent manner. Conclusion: Very high concentrations of NUCs may have a novel potential to kill replicating HBV-expressing liver tumor cells.
引用
收藏
页码:6059 / 6069
页数:11
相关论文
共 34 条
  • [1] Apoptosis of Hepatitis B Virus-Infected Hepatocytes Prevents Release of Infectious Virus
    Arzberger, Silke
    Hoesel, Marianna
    Protzer, Ulrike
    [J]. JOURNAL OF VIROLOGY, 2010, 84 (22) : 11994 - 12001
  • [2] Nucleos(t)ide analogs in the prevention of hepatitis B virus related hepatocellular carcinoma
    Baran, Bulent
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (13) : 1742 - 1754
  • [3] Inactivation of Hepatitis B Virus Replication in Cultured Cells and In Vivo with Engineered Transcription Activator-Like Effector Nucleases
    Bloom, Kristie
    Ely, Abdullah
    Mussolino, Claudio
    Cathomen, Toni
    Arbuthnot, Patrick
    [J]. MOLECULAR THERAPY, 2013, 21 (10) : 1889 - 1897
  • [4] Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years
    Buti, Maria
    Fung, Scott
    Gane, Edward
    Afdhal, Nezam H.
    Flisiak, Robert
    Gurel, Selim
    Flaherty, John F.
    Martins, Eduardo B.
    Yee, Leland J.
    Dinh, Phillip
    Bornstein, Jeffrey D.
    Subramanian, G. Mani
    Janssen, Harry L. A.
    George, Jacob
    Marcellin, Patrick
    [J]. HEPATOLOGY INTERNATIONAL, 2015, 9 (02) : 243 - 250
  • [5] Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease
    Cho, Ju-Yeon
    Paik, Yong-Han
    Sohn, Won
    Cho, Hyun Chin
    Gwak, Geum-Youn
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    Yoo, Byung Chul
    [J]. GUT, 2014, 63 (12) : 1943 - 1950
  • [6] High Viremia, Prolonged Lamivudine Therapy and Recurrent Hepatocellular Carcinoma Predict Posttransplant Hepatitis B Recurrence†
    Chun, J.
    Kim, W.
    Kim, B. G.
    Lee, K. L.
    Suh, K. -S.
    Yi, N. -J.
    Park, K. U.
    Kim, Y. J.
    Yoon, J. -H.
    Lee, H. S.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (07) : 1649 - 1659
  • [7] Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation
    Faria, Luciana C.
    Gigou, Michelle
    Roque-Afonso, Anne M.
    Sebagh, Mylene
    Roche, Bruno
    Fallot, Guillaume
    Ferrari, Teresa C. A.
    Guettier, Catherine
    Dussaix, Elisabeth
    Castaing, Denis
    Brechot, Christian
    Samuel, Didier
    [J]. GASTROENTEROLOGY, 2008, 134 (07) : 1890 - 1899
  • [8] Selection of chronic hepatitis B therapy with high barrier to resistance
    Gish, Robert
    Jia, Ji-Dong
    Locarnini, Stephen
    Zoulim, Fabien
    [J]. LANCET INFECTIOUS DISEASES, 2012, 12 (04) : 341 - 353
  • [9] Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics
    Guo, Ju-Tao
    Guo, Haitao
    [J]. ANTIVIRAL RESEARCH, 2015, 122 : 91 - 100
  • [10] Hepatic Arterial Embolization with Doxorubicin-Loaded Superabsorbent Polymer Microspheres in a Rabbit Liver Tumor Model
    Gupta, Sanjay
    Wright, Kenneth C.
    Ensor, Joe
    Van Pelt, Carolyn S.
    Dixon, Katherine A.
    Kundra, Vikas
    [J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2011, 34 (05) : 1021 - 1030